(Q27689624)
Statements
Identification of novel HSP90α/β isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease (English)
0 references
24 April 2014
0 references
57
0 references
8
0 references
3382-400
0 references